This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Sep;43(9):1200-1.

doi: 10.1093/rheumatology/keh288.

The HAQ disability index in scleroderma trials

S R Johnson, P Lee

PMID: 15317965
DOI: 10.1093/rheumatology/keh288

Comment

The HAQ disability index in scleroderma trials

S R Johnson et al. Rheumatology (Oxford). 2004 Sep.

. 2004 Sep;43(9):1200-1.

doi: 10.1093/rheumatology/keh288.

Authors

S R Johnson, P Lee

PMID: 15317965
DOI: 10.1093/rheumatology/keh288

No abstract available

PubMed Disclaimer

Comment on

The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma.
Sultan N, Pope JE, Clements PJ; Scleroderma Trials Study Group. Sultan N, et al. Rheumatology (Oxford). 2004 Apr;43(4):472-8. doi: 10.1093/rheumatology/keh070. Epub 2003 Dec 16. Rheumatology (Oxford). 2004. PMID: 14679295 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems